EdwardFAttiyehMD
Pediatric Hematology & Oncology • Philadelphia, PAAssistant Professor, Pediatrics, Perelman School of Medicine
Dr. Attiyeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
34th & Civic Center Blvd.
Children's Hospital Of Philadelphia
Philadelphia, PA 19104Phone+1 215-590-1000Fax+1 215-561-0959- Is this information wrong?
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2002 - 2005
Yale-New Haven Medical CenterResidency, Pediatrics, 1999 - 2002
Albert Einstein College of MedicineClass of 1999
Certifications & Licensure
PA State Medical License 2002 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
- Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- A Phase I, Randomized, Multi-Dose Study to Evaluate the Enteric Selectivity and Safety of JAK Inhibitor, Lorpucitinib, in Healthy Participants.Xuewen Ma, Gary Borzillo, Martine J Christine Kothe, Madhu Sanga, Gerald Chu, James G Greger, Annemie Deiteren, Edward Attiyeh> ;Clinical Pharmacology and Therapeutics. 2024 May 1
- 8 citationsPhase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer.Emerson A Lim, Michael T Schweizer, Kim N Chi, Rahul Aggarwal, Neeraj Agarwal, James Gulley, Edward Attiyeh, James Greger, Shujian Wu, Pharavee Jaiprasart, John Loffre...> ;Clinical Genitourinary Cancer. 2023 Jun 1
- 6 citationsFirst-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with adva...Enriqueta Felip, Victor Moreno, Daniel Morgensztern, Giuseppe Curigliano, Piotr Rutkowski, José Manuel Trigo, Aitana Calvo, Dariusz Kowalski, Diego Cortinovis, Ruth Pl...> ;Cancer Chemotherapy and Pharmacology. 2022 Apr 1
- Join now to see all
Grant Support
- Discovery Of Chromosome Arm 11q Tumor Suppressor Genes In NeuroblastomaNational Cancer Institute2006–2010
Professional Memberships
- Member
Hospital Affiliations
Children's Hospital of PhiladelphiaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
